Schoffelmeer A N, Putters J, Mulder A H
Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):377-80. doi: 10.1007/BF00500012.
3H-noradrenaline release from rat neocortical slices induced by 15 mM K+ was concentration-dependently inhibited by morphine, [D-Ala2-D-Leu5] enkephalin (DADLE) and the calcium entry blocker Cd2+. Blockade of presynaptic alpha 2-adrenoceptors with phentolamine, almost doubling K+-induced 3H-noradrenaline release, slightly enhanced the relative inhibitory effects of morphine and DADLE, whereas that of Cd2+ remained unaffected. In contrast, activation of presynaptic alpha 2-adrenoceptors with clonidine (1 microM) or TL-99 (1 microM), inhibiting release by about 50%, completely abolished the inhibitory effects of morphine and DADLE without affecting that of Cd2+. When in the presence of 1 microM clonidine adenylate cyclase was activated with forskolin (10 microM), which restored release to the drug-free control level, the opioids still did not display their inhibitory effects. Therefore, mu-opioid receptor efficacy appears to be dependent on the degree of activation of alpha 2-adrenoceptors in central noradrenergic nerve terminals, probably through a local receptor interaction within the nerve terminal membrane.
15 mM钾离子诱导大鼠新皮质切片释放3H-去甲肾上腺素的过程,受到吗啡、[D-丙氨酸2-D-亮氨酸5]脑啡肽(DADLE)和钙通道阻滞剂Cd2+的浓度依赖性抑制。用酚妥拉明阻断突触前α2-肾上腺素能受体,使钾离子诱导的3H-去甲肾上腺素释放量几乎增加一倍,同时略微增强了吗啡和DADLE的相对抑制作用,而Cd2+的抑制作用不受影响。相反,用可乐定(1 microM)或TL-99(1 microM)激活突触前α2-肾上腺素能受体,使释放量抑制约50%,完全消除了吗啡和DADLE的抑制作用,而不影响Cd2+的抑制作用。当存在1 microM可乐定时,用福斯可林(10 microM)激活腺苷酸环化酶,使释放量恢复到无药对照水平,此时阿片类药物仍未表现出其抑制作用。因此,μ-阿片受体的效能似乎取决于中枢去甲肾上腺素能神经末梢α2-肾上腺素能受体的激活程度,可能是通过神经末梢膜内的局部受体相互作用实现的。